CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for JW Pharmaceutical Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

JW Pharmaceutical Corp
JW Tower, 38, Gwacheon-daero 7-gil
Phone: +82 28406777p:+82 28406777 GWACHEON, 13840  South Korea Ticker: 001060001060
Business Summary
JW Pharmaceutical Corp is a Korea-based company engaged in the development and manufacturing of pharmaceuticals. The Company mainly produces and sells pharmaceuticals such as blood hyperlipidemia treatment drugs, blood protein amino acid supply drugs, blood and body fluid substitutes, hemophilia treatment drugs, electrolyte additives, rheumatoid arthritis treatment drugs, hepatic coma treatment drugs, perfusion solutions, and iron injections. The Company also researches and develops anticancer drugs.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman Gyeong HaLee 58 3/22/2018
Chief Executive Officer, Director Yeong SeopShin 58 3/29/2022 3/17/2017
Chief Financial Officer, Director Ji WuChoi 58
11 additional Officers and Directors records available in full report.

Business Names
Business Name
001060
001065
001067
Choongwae Pharma Corp
Choongwae Pharmaceutical Corp
Euvipharm

General Information
Number of Employees: 1,095 (As of 12/31/2015)
Outstanding Shares: 23,324,537 (As of 9/30/2024)
Shareholders: 29,970
Stock Exchange: KRX
Fax Number: +82 28437696


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024